Rockwell Medical (RMTI) Common Equity (2010 - 2026)

Rockwell Medical's Common Equity history runs 17 years deep, the most recent figure standing at $4000.0 for Q1 2026.

• Quarterly Common Equity fell 99.99% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 99.99% YoY) and the FY2025 annual result came in at $37.0 million, up 13.49% from the prior year.
• Common Equity was $4000.0 for Q1 2026 at Rockwell Medical, down from $37.0 million in the prior quarter.
• Across five years, Common Equity topped out at $37.0 million in Q3 2025 and bottomed at -$4.8 million in Q1 2022.
• A 5-year average of $20.7 million and a median of $21.3 million in 2023 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 456.45% in 2022, while the deepest fall reached 118.36% in 2022.
• Rockwell Medical's Common Equity stood at $14.1 million in 2022, then jumped by 50.94% to $21.3 million in 2023, then soared by 53.05% to $32.6 million in 2024, then advanced by 13.49% to $37.0 million in 2025, then plunged by 99.99% to $4000.0 in 2026.
• Business Quant data shows RMTI's Common Equity at $4000.0 in Q1 2026, $37.0 million in Q4 2025, and $37.0 million in Q3 2025.